PSNL · US market
PERSONALIS
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$1.73bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$107.18m
- Latest-quarter run-rate earnings
- -US$126.73m
- Latest fiscal-year earnings
- -US$81.27m
- Trailing revenue
- US$69.67m
- Latest-quarter run-rate revenue
- US$89.43m
- Latest fiscal-year revenue
- US$69.65m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- ARKG.L · ARK Genomic Revolution UCITS ETF4.46% weight · Holdings dated 3 August 2026
- ARKG · ARK Genomic Revolution ETF3.58% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- IDNA · iShares Genomics Immunology and Healthcare ETF1.05% weight · Holdings dated 21 August 2026
- GNOM · Global X Genomics & Biotechnology ETF0.76% weight · Holdings dated 31 May 2026
- ACRSX · Columbia Acorn Fund Class S0.62% weight · Holdings dated 30 June 2026
- CMSHX · Columbia Small Cap Growth Fund Class S0.58% weight · Holdings dated 31 May 2026
- IWC · iShares Micro-Cap ETF0.28% weight · Holdings dated 21 August 2026
- TMED · T. Rowe Price Health Care ETF0.12% weight · Holdings dated 30 June 2026
- GINN · Goldman Sachs Innovate Equity ETF0.10% weight · Holdings dated 31 May 2026
- BDSIX · BlackRock Advantage Small Cap Core Fund Institutional Shares0.08% weight · Holdings dated 29 May 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.